Two Sigma Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.66M | Buy |
272,800
+223,100
| +449% | +$5.94M | 0.01% | 1622 |
|
|
2025
Q4 | $1.24M | Buy |
+49,700
| New | +$1.25M | ﹤0.01% | 2778 |
|
|
2022
Q1 | – | Sell |
-161,900
| Closed | -$9.56M | – | 3913 |
|
|
2021
Q4 | $9.56M | Buy |
161,900
+95,800
| +145% | +$4.75M | 0.02% | 811 |
|
|
2021
Q3 | $2.84M | Sell |
66,100
-123,700
| -65% | -$5.48M | 0.01% | 1659 |
|
|
2021
Q2 | $7.43M | Sell |
189,800
-996,100
| -84% | -$38.7M | 0.02% | 977 |
|
|
2021
Q1 | $43M | Buy |
+1,185,900
| New | +$42.1M | 0.11% | 208 |
|
|
2020
Q4 | – | Sell |
-8,537
| Closed | -$297K | – | 3655 |
|
|
2020
Q3 | $297K | Sell |
8,537
-17,286
| -67% | -$606K | ﹤0.01% | 2582 |
|
|
2020
Q2 | $801K | Sell |
25,823
-412,430
| -94% | -$14M | ﹤0.01% | 1679 |
|
|
2020
Q1 | $13.6M | Buy |
438,253
+275,305
| +169% | +$9.38M | 0.11% | 189 |
|
|
2019
Q4 | $6.06M | Sell |
162,948
-1,149,598
| -88% | -$40.9M | 0.02% | 850 |
|
|
2019
Q3 | $44.7M | Buy |
1,312,546
+926,360
| +240% | +$33.7M | 0.15% | 172 |
|
|
2019
Q2 | $15.9M | Sell |
386,186
-165,688
| -30% | -$6.58M | 0.05% | 420 |
|
|
2019
Q1 | $22.2M | Buy |
551,874
+500,650
| +977% | +$20.1M | 0.07% | 356 |
|
|
2018
Q4 | $2.12M | Sell |
51,224
-192,566
| -79% | -$7.99M | 0.01% | 1211 |
|
|
2018
Q3 | $10.2M | Sell |
243,790
-645,681
| -73% | -$24.9M | 0.03% | 633 |
|
|
2018
Q2 | $30.6M | Sell |
889,471
-63,240
| -7% | -$2.16M | 0.09% | 293 |
|
|
2018
Q1 | $32.1M | Buy |
952,711
+585,181
| +159% | +$20.1M | 0.11% | 239 |
|
|
2017
Q4 | $12.6M | Sell |
367,530
-2,002
| -0.5% | -$68.3K | 0.04% | 515 |
|
|
2017
Q3 | $12.5M | Sell |
369,532
-176,756
| -32% | -$5.68M | 0.04% | 443 |
|
|
2017
Q2 | $17.4M | Sell |
546,288
-1,629,379
| -75% | -$51.4M | 0.06% | 369 |
|
|
2017
Q1 | $70.6M | Buy |
2,175,667
+1,617,890
| +290% | +$51M | 0.24% | 90 |
|
|
2016
Q4 | $17.2M | Sell |
557,777
-743,702
| -57% | -$22.7M | 0.07% | 355 |
|
|
2016
Q3 | $41.8M | Sell |
1,301,479
-224,081
| -15% | -$7.49M | 0.15% | 146 |
|
|
2016
Q2 | $51M | Buy |
1,525,560
+1,078,348
| +241% | +$34.4M | 0.22% | 103 |
|
|
2016
Q1 | $12.6M | Buy |
447,212
+112,462
| +34% | +$3.21M | 0.06% | 377 |
|
|
2015
Q4 | $10.3M | Buy |
334,750
+296,806
| +782% | +$9.34M | 0.05% | 415 |
|
|
2015
Q3 | $1.13M | Sell |
37,944
-172,856
| -82% | -$5.54M | 0.01% | 1127 |
|
|
2015
Q2 | $6.71M | Sell |
210,800
-160,208
| -43% | -$5.22M | 0.03% | 590 |
|
|
2015
Q1 | $12.2M | Buy |
+371,008
| New | +$11.8M | 0.06% | 405 |
|
Other funds holding PFE
VCM
VPM
Two Sigma Investments's PFE Position: Q1 2026 in Review
Two Sigma Investments reduced its Pfizer (PFE) stake by 90% in Q1 2026, selling an estimated $49.4M and leaving 212,100 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.
Two Sigma Investments first reported a position in PFE in Q3 2013 and has held it in 41 quarters since. The position peaked at $271M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Two Sigma Investments held 212,100 shares of Pfizer worth $5.96M as of Q1 2026.
- Two Sigma Investments sold 1,856,008 Pfizer shares in Q1 2026, an estimated $49.4M.
- Pfizer made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1816 holding.
- Two Sigma Investments first reported a position in Pfizer in Q3 2013 and has held it in 41 quarters since.
- Two Sigma Investments's Pfizer position peaked at $271M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.